Jefferies resumed coverage on Omega Therapeutics with a new price target

5/25/23 7:51:53 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Jefferies resumed coverage of Omega Therapeutics with a rating of Buy and set a new price target of $15.00 from $18.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$OMGA

Date	Price Target	Rating	Analyst
11/15/2024		Outperform → Mkt Perform	Raymond James
6/18/2024	$12.00	Outperform	Raymond James
5/25/2023	$18.00 → $15.00	Buy	Jefferies
12/8/2022	$11.00	Buy	H.C. Wainwright
9/23/2022	$12.00	Buy	Chardan Capital Markets
8/24/2021	$36.00	Outperform	Wedbush
8/24/2021	$30.00	Buy	Jefferies
8/24/2021	$30.00	Overweight	Piper Sandler